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Nine cat isolates and nine dog isolates of Rhodococcus equi from clinical material were investigated for the
presence of the virulence-associated antigens (VapA and VapB) and virulence plasmids. Five of the cat isolates
and one dog isolate were VapA positive and contained an 85-kb type I or an 87-kb type I plasmid. The
remaining 12 isolates were avirulent R. equi strains and contained no virulence plasmids.
Rhodococcus equi is a facultative, intracellular, gram-posi-
tive coccobacillus that causes chronic suppurative broncho-
pneumonia and enteritis and is associated with a high mortality
rate in 1- to 3-month-old foals (1, 15, 16). It has also been
isolated from the submaxillary lymph nodes of pigs (18) and
the lymph nodes of cattle (8). R. equi infection is increasing in
prominence in immunocompromised humans, particularly
those infected with human immunodeficiency virus (9, 12, 27).
Although R. equi infections in species other than horses (foals)
are rare and are regarded as opportunistic, they have recently
been increasingly reported in cats and dogs (5, 6, 7, 10, 11, 13,
14). In cats, pyogranulomatous lesions are the characteristic
symptom, with primary involvement of the extremities in most
affected cats (14).
The discovery of virulence-associated antigens and virulence
plasmids has allowed the virulence of R. equi strains to be
classified (24, 26). At least three levels of virulence have been
identified for R. equi: virulent, intermediately virulent, and
avirulent (16). Virulent R. equi is characterized by the presence
of 15- to 17-kDa virulence-associated antigens (VapA) and
virulence plasmid DNA of 80 to 90 kb (21, 24, 25), and these
strains are found in the pulmonary or intestinal lesions of foals
and in the pulmonary lesions of AIDS patients (murine 50%
lethal dose [LD50]  10
6 bacteria) (23). R. equi strains of
intermediate virulence are identified by a 20-kDa virulence-
associated antigen (VapB) and virulence plasmid DNA of 79
to 100 kb and are found in the submaxillary lymph nodes of
pigs (murine LD50  10
7 bacteria) and the pulmonary lesions
of AIDS patients (22). In contrast, avirulent R. equi shows
evidence of neither virulence-associated antigens nor plasmid
DNA (murine LD5010
8 bacteria) and is widespread in soil
(16). It is noteworthy that the majority of R. equi isolates from
AIDS patients are virulent or intermediately virulent, whereas
those from patients with immunosuppression derived from
other causes are avirulent (22, 23).
Exposure to manure and soils contaminated with the ma-
nure of domestic animals such as horses, cattle, and pigs may
be one of the possible routes of infection in humans (15, 16).
Cats and dogs infected with R. equi have not been considered
to be a source of infection for humans, who usually acquire the
infection from environmental exposure. Nevertheless, infected
cats and dogs with discharges may pose some theoretical risk to
immunocompromised owners (9, 12, 27). There have been few
studies that include the plasmid profiles or report the presence
of VapA in isolates from companion animals (19, 26). There-
fore, the pathogenicity of R. equi isolates from cats and dogs
remains unclear. The purposes of this study were to investigate
the presence of vap genes in 18 R. equi isolates from cats and
dogs and to examine the plasmid profiles of these isolates.
The clinical isolates of R. equi used in the present study are
listed in Table 1. Five cat isolates and seven dog isolates were
obtained from the College of Veterinary Medicine, Texas
A&M University; two cat isolates and two dog isolates were
from Ontario Veterinary College, University of Guelph; and
one cat isolate each was from New Zealand and Brazil. Al-
though the respiratory tract is not a principal site of infection
in these animals, nasal swabs were collected from three dogs.
Extrapulmonary infection was more common in both cats and
dogs, including wound infections, subcutaneous abscesses, vag-
initis, hepatitis, osteomyelitis, myositis, and joint infections.
Swabs were also collected from the eyes and ears of these
animals. Unfortunately, details of the clinical manifestations
were not available in most cases.
Eighteen isolates were examined for VapA and VapB by
colony blot enzyme-linked immunosorbent assay with mono-
clonal antibodies (20, 22). The target DNAs for PCR amplifi-
cation were the published sequences of the 15- to 17-kDa
antigen (VapA) gene and the 20-kDa antigen (VapB) gene
(GenBank database accession numbers D21236l and D44469,
respectively) from R. equi strain ATCC 33701 and isolate 5,
respectively (4, 21). PCR amplification was performed as de-
scribed previously (4, 21). Plasmid DNA was isolated from R.
equi by the alkaline lysis method (3), with some modifications
as described previously (24). Plasmid DNAs were analyzed by
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digestion with restriction endonucleases EcoRI, EcoT22I, and
HindIII for detailed comparisons and to estimate plasmid
sizes. The bacterial strains used as reference strains in this
study were R. equi ATCC 33701 (85-kb type I plasmid), 96E35
(85-kb type II plasmid), T47-2 (85-kb type III plasmid), T43
(85-kb type IV plasmid), 222 (87-kb type I plasmid), 96B6
(87-kb type II plasmid), and L1 (90-kb type I plasmid) (17, 25).
Of the nine clinical isolates from cats, five isolates from
Brazil, Canada, New Zealand, and the United States were
positive for vapA and virulence plasmid DNA. Of the nine
clinical isolates from dogs, one isolate from the United States
was positive for vapA and virulence plasmid DNA. The re-
maining four cat and eight dog isolates were negative for both
virulence-associated antigens and plasmids. The six isolates
expressing VapA and a positive control, ATCC 33701, pro-
duced positive results in the PCR, showing a 547-bp amplifi-
cation product. Plasmid DNA preparations from the six iso-
lates were analyzed by restriction enzyme digestion with the
four endonucleases, and four of the six isolates contained an
85-kb type I plasmid and the remaining two isolates contained
an 87-kb type I plasmid.
There have been sporadic reports in the literature of Rhodo-
coccus infections in cats associated with mediastinal and mes-
enteric lymphadenitis (11) and cellulitis and abscesses, mainly
of the extremities (6, 7, 10, 13) and of the neck (14). More
recently, reports of R. equi infections in dogs have appeared
(5). Although the number of cases is increasing, the virulence
of the feline and canine isolates has not previously been char-
acterized. In this study, we examined 18 cat and dog isolates
from the Americas and New Zealand and found that five of the
nine cat isolates and one of the nine dog isolates were R. equi
VapA positive and that the remaining isolates were avirulent.
Fisher’s exact test indicated that there was no statistically sig-
nificant difference between the nine isolates from cats and the
nine isolates from dogs. However, when the data (shown in
Table 1) from previous studies (5, 19, 26) were added into the
statistical analysis, there was a significant difference between
the 11 cat isolates and the 13 dog isolates. These results may
reflect differences between the features of cat and dog infec-
tions, such as the source or route of infection or the predis-
posing factors of the hosts.
Virulent, but not avirulent, R. equi can produce pneumonic
disease in foals experimentally (16), and clinical isolates from
naturally infected foals have all been virulent R. equi strains
expressing VapA (16, 24). On the other hand, the majority of
pig isolates are intermediately virulent R. equi strains express-
ing VapB (18). VapA-positive R. equi is widespread in the
environments of horse-breeding farms (16), and VapB-positive
R. equi is largely restricted to the environments of pig farms
(18). Previous studies thus suggest that VapA-positive R. equi
isolates from cats and dog should be derived from horses or
their environments (16). The plasmid profiles of VapA-posi-
tive isolates from cats and dogs also indicate that these isolates
may be closely associated with those from horses, because
either 85-kb type I or 87-kb type I plasmids have been found in
clinical isolates from foals in North and South America (17,
25). However, little is known about the source and mode of R.
equi infections in cats and dogs. Exposure to soil contaminated
TABLE 1. Source, presence of vapA and vapB genes, and plasmid profiles of R. equi isolates from cats and dogs









C98037174 1998 Cat Male 10 yr Unknown a  United States
C98326079 1998 Cat Male Unknown Abdominal wound   United States
D9210985 1999 Cat Female Unknown Abscess with an associated
adenocarcinoma
  85 United States
C000910124 2000 Cat Male 1 yr Ear swab   United States
C012570132 2001 Cat Male Unknown Wound   85 United States
Ruakura 1 2000 Cat Male Unknown Necrotic tissue on leg   85 New Zealand
Isolate F1 1977 Cat Unknown Unknown Unknown   85 Canada
FD-118
Isolate F2 1979–6048 1979 Cat Unknown Unknown Abscess   Canada
Isolate 8 1994 Cat Male 2 yr Ulcerated tissue on leg   87 Brazil
Isolate 102 Unknown Cat Unknown Unknown Clinical material   85 26; Canadab
Isolate 23 Unknown Cat Unknown Unknown Clinical material   85 26; Canadab
C98219287 1998 Pekinese Male 11 yr Nasal swab   United States
C98293165 1998 Golden retriever Female 8 yr Nasal lesion   United States
TAMU135318 2000 Dog Unknown Unknown Joint   United States
18711 2001 Dog Unknown Unknown Mass   United States
C001150191 2000 Dog Female 12 yr Eye   87 United States
C012340021 2001 Dog Female 5 yr Nasal lesion   United States
C012630142 2001 Dog Male 7 mo Eye   United States
Isolate CI 1977–3725 1977 Dog Unknown Unknown Skin swab   Canada
Isolate C2 1998-28764 1998 Dog Unknown Puppy Vaginitis   Canada
Isolate Unknown Basenji dog Female 3 mo Necrotizing pyogranulo-
matous hepatitis, osteo-
myelitis, myositis
  5; United Statesb
4527 1997 Dog Unknown Unknown Chronic tracheitis   19; South Africab
ATCC 33702 Unknown Dog Unknown Unknown Clinical material (skin)   26; Canadab
Isolate 5 Unknown Dog Unknown Unknown Clinical material (skin)   26; Canadab
a Symbols: , present; , not present.
b Data are from Cantor et al. (5), Takai et al. (19), and Tkachuk-Saad et al. (26).
c 85, 85-kb type I; 87, 87-kb type I.










with livestock manure is likely to be the major route of infec-
tion for these companion animals. The most probable mode of
infection could involve the establishment of R. equi in subcu-
taneous tissues after a penetrating wound is contaminated
from environmental sources, with subsequent hematogenous
dissemination to the spleen and local spread to the peritoneal
cavity (14). In the present study, a Brazilian cat from which
isolate 8 was recovered had had contact with horses and cows,
but we have no information about the exposure of the other
animals from which isolates were taken.
In the nine dog isolates, one isolate was from a puppy and
three were from old dogs, suggesting that immaturity and im-
pairment of the immune system may be predisposing factors.
Cantor et al. (5) also discussed the possibility of intrinsic de-
fects of the immune system in their 3-month-old animal.
In humans, R. equi infections have primarily been reported
in association with human immunodeficiency virus infections
and other immunosuppressive diseases or therapy (27). The
majority of cat isolates in this and previous studies were viru-
lent R. equi strains (26). It is very interesting that the preva-
lence of virulent R. equi in cats and dogs is very similar to that
in patients with and without AIDS, respectively (22, 23). Feline
immunodeficiency virus (FIV)-infected cats are found world-
wide (2). In the United States, approximately 1.5 to 3% of
healthy cats are infected with FIV (2). Infection rates rise
significantly in cats that are sick; up to 15% of cats with clinical
signs of other diseases are also infected with FIV (2). In the
present study, there was no information on the FIV status of
the nine cats analyzed, but the high seroprevalence of FIV in
clinically ill cats suggests that some of the feline R. equi infec-
tions studied were probably associated with FIV infections (2).
R. equi infections in companion animals have been thought
to be very rare, but they may be increasing in cats and dogs. It
is possible, however, that in the past, laboratories have misi-
dentified colonies of R. equi as contaminants in routine bacte-
riological examination of specimens from cats and dogs or that
such isolates were not reported in the literature, even when
correctly identified. Further epidemiological surveillance may
clarify the incidence of R. equi infection and the factors pre-
disposing cats and dogs to this infection.
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